PMH37 THE COST-EFFECTIVENESS OF GUANFACINE EXTENDED RELEASE (GXR) VERSUS ATOMOXETINE (ATX) FOR THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN CHILDREN AND ADOLESCENTS
作者
M. Haim Erder,K. Chen,E.Q. Wu,P. Hodgkins,Vanja Sikirica
出处
期刊:Value in Health [Elsevier BV] 日期:2011-05-01卷期号:14 (3): A192-A192被引量:1